OBJECTIVE: To examine the prevalence and correlates of non-opioid and opioid analgesic use and descriptively evaluate potential undertreatment in a sample of community-dwelling elders with symptomatic knee and/or hip osteoarthritis (OA). DESIGN: Cross-sectional. SETTING: Health, Aging, and Body Composition Study. PATIENTS: Six hundred and fifty-two participants attending the year 6 visit (2002-03) with symptomatic knee and/or hip OA. OUTCOME MEASURES: Analgesic use was defined as taking ≥1 non-opioid and/or ≥1 opioid receptor agonist. Non-opioid and opioid doses were standardized across all agents by dividing the daily dose used by the minimum effective analgesic daily dose. Inadequate pain control was defined as severe/extreme OA pain in the past 30 days from a modified Western Ontario and McMaster Universities Osteoarthritis Index. RESULTS: Just over half (51.4%) reported taking at least one non-opioid analgesic and approximately 10% was taking an opioid, most (88.5%) of whom also took a non-opioid. One in five participants (19.3%) had inadequate pain control, 39% of whom were using <1 standardized daily dose of either a non-opioid or opioid analgesic. In adjusted analyses, severe/extreme OA pain was significantly associated with both non-opioid (adjusted odds ratio [AOR] = 2.44; 95% confidence interval [95% CI] = 1.49-3.99) and opioid (AOR = 2.64; 95% CI = 1.26-5.53) use. CONCLUSIONS: Although older adults with severe/extreme knee and/or hip OA pain are more likely to take analgesics than those with less severe pain, a sizable proportion takes less than therapeutic doses and thus may be undertreated. Further research is needed to examine barriers to optimal analgesic use. Wiley Periodicals, Inc.
OBJECTIVE: To examine the prevalence and correlates of non-opioid and opioid analgesic use and descriptively evaluate potential undertreatment in a sample of community-dwelling elders with symptomatic knee and/or hip osteoarthritis (OA). DESIGN: Cross-sectional. SETTING: Health, Aging, and Body Composition Study. PATIENTS: Six hundred and fifty-two participants attending the year 6 visit (2002-03) with symptomatic knee and/or hip OA. OUTCOME MEASURES: Analgesic use was defined as taking ≥1 non-opioid and/or ≥1 opioid receptor agonist. Non-opioid and opioid doses were standardized across all agents by dividing the daily dose used by the minimum effective analgesic daily dose. Inadequate pain control was defined as severe/extreme OA pain in the past 30 days from a modified Western Ontario and McMaster Universities Osteoarthritis Index. RESULTS: Just over half (51.4%) reported taking at least one non-opioid analgesic and approximately 10% was taking an opioid, most (88.5%) of whom also took a non-opioid. One in five participants (19.3%) had inadequate pain control, 39% of whom were using <1 standardized daily dose of either a non-opioid or opioid analgesic. In adjusted analyses, severe/extreme OA pain was significantly associated with both non-opioid (adjusted odds ratio [AOR] = 2.44; 95% confidence interval [95% CI] = 1.49-3.99) and opioid (AOR = 2.64; 95% CI = 1.26-5.53) use. CONCLUSIONS: Although older adults with severe/extreme knee and/or hip OA pain are more likely to take analgesics than those with less severe pain, a sizable proportion takes less than therapeutic doses and thus may be undertreated. Further research is needed to examine barriers to optimal analgesic use. Wiley Periodicals, Inc.
Authors: M Pahor; J M Guralnik; J Y Wan; L Ferrucci; B W Penninx; A Lyles; S Ling; L P Fried Journal: Am J Public Health Date: 1999-06 Impact factor: 9.308
Authors: Kelli L Dominick; Hayden B Bosworth; Amy S Jeffreys; Steven C Grambow; Eugene Z Oddone; Ronnie D Horner Journal: Pharmacoepidemiol Drug Saf Date: 2004-10 Impact factor: 2.890
Authors: W Zhang; R W Moskowitz; G Nuki; S Abramson; R D Altman; N Arden; S Bierma-Zeinstra; K D Brandt; P Croft; M Doherty; M Dougados; M Hochberg; D J Hunter; K Kwoh; L S Lohmander; P Tugwell Journal: Osteoarthritis Cartilage Date: 2008-02 Impact factor: 6.576
Authors: Ronica N Rooks; Eleanor M Simonsick; Lisa M Klesges; Anne B Newman; Hilsa N Ayonayon; Tamara B Harris Journal: J Aging Health Date: 2008-07-14
Authors: Ronica N Rooks; Eleanor M Simonsick; Toni Miles; Anne Newman; Stephen B Kritchevsky; Richard Schulz; Tamara Harris Journal: J Gerontol B Psychol Sci Soc Sci Date: 2002-07 Impact factor: 4.077
Authors: Zachary A Marcum; Subashan Perera; Anne B Newman; Joshua M Thorpe; Galen E Switzer; Shelly L Gray; Eleanor M Simonsick; Ronald I Shorr; Douglas C Bauer; Nicholas G Castle; Stephanie A Studenski; Joseph T Hanlon Journal: J Gerontol A Biol Sci Med Sci Date: 2015-08-11 Impact factor: 6.053
Authors: E R Vina; L R M Hausmann; D S Obrosky; A Youk; S A Ibrahim; D K Weiner; R M Gallagher; C K Kwoh Journal: Osteoarthritis Cartilage Date: 2019-02-01 Impact factor: 6.576
Authors: Zachary A Marcum; Subashan Perera; Joshua M Thorpe; Galen E Switzer; Shelly L Gray; Nicholas G Castle; Elsa S Strotmeyer; Eleanor M Simonsick; Douglas C Bauer; Ronald I Shorr; Stephanie A Studenski; Joseph T Hanlon Journal: Ann Pharmacother Date: 2015-07-30 Impact factor: 3.154
Authors: Zachary A Marcum; Subashan Perera; Joshua M Thorpe; Galen E Switzer; Nicholas G Castle; Elsa S Strotmeyer; Eleanor M Simonsick; Hilsa N Ayonayon; Caroline L Phillips; Susan Rubin; Audrey R Zucker-Levin; Douglas C Bauer; Ronald I Shorr; Yihuang Kang; Shelly L Gray; Joseph T Hanlon Journal: Ann Pharmacother Date: 2016-04-11 Impact factor: 3.154
Authors: Zachary A Marcum; Joseph T Hanlon; Elsa S Strotmeyer; Anne B Newman; Ronald I Shorr; Eleanor M Simonsick; Douglas C Bauer; Robert Boudreau; Julie M Donohue; Subashan Perera Journal: J Am Geriatr Soc Date: 2014-10-03 Impact factor: 5.562